Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 1.5M | 2.7M | 1.5M | 3.3M | 1.9M | -- |
| Operating Revenue | 1.5M | 2.7M | 1.5M | 3.3M | 1.9M | -- |
| Cost Of Revenue | 862,000 | 1.8M | 1.1M | 1.3M | 914,000 | -- |
| Gross Profit | 621,000 | 974,000 | 443,000 | 2.0M | 957,000 | -- |
| Selling General And Administration | 2.1M | 2.6M | 2.9M | 2.7M | 3.0M | -- |
| General And Administrative Expense | 2.1M | -- | -- | 2.7M | 3.0M | 3.0M |
| Research And Development | 527,000 | 690,000 | 1.1M | 2.9M | 2.8M | -- |
| Operating Expense | 2.6M | 3.3M | 4.1M | 5.7M | 5.8M | -- |
| Operating Income | -2.0M | -2.4M | -3.6M | -3.6M | -4.8M | -- |
| EBIT | -1.8M | -2.7M | -3.6M | -5.6M | -5.8M | -- |
| Interest Expense | 43,000 | 23,000 | 70,000 | 23,000 | 22,000 | -- |
| Interest Expense Non Operating | 43,000 | 23,000 | 70,000 | 23,000 | 22,000 | -- |
| Interest Income | 57,000 | 83,000 | 106,000 | -- | 210,000 | 83,000 |
| Interest Income Non Operating | 57,000 | 83,000 | 106,000 | -- | 210,000 | 83,000 |
| Net Interest Income | 14,000 | 60,000 | 36,000 | 418,000 | 188,000 | -- |
| Other Income Expense | 174,000 | -407,000 | -74,000 | -2.5M | -1.2M | -- |
| Other Non Operating Income Expenses | 4,000 | 8,000 | 8,000 | -291,000 | 21,000 | -- |
| Special Income Charges | -316,000 | -- | -- | -2.8M | -1.5M | -- |
| Write Off | 76,000 | -- | -- | -- | 0.00 | -- |
| Gain On Sale Of Security | 486,000 | -415,000 | -82,000 | 632,000 | 217,000 | -- |
| Pretax Income | -1.8M | -2.7M | -3.7M | -5.6M | -5.9M | -- |
| Tax Provision | 0.00 | 1,000 | 0.00 | 1.1M | -112,000 | -- |
| Tax Effect Of Unusual Items | 0.00 | -62,250 | 0.00 | -324,900 | -23,710 | -- |
| Net Income From Continuing And Discontinued Operation | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| Net Income From Continuing Operation Net Minority Interest | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| Net Income Including Noncontrolling Interests | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| Net Income Common Stockholders | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| Net Income | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| EBITDA | -1.5M | -2.4M | -3.3M | -5.2M | -5.4M | -- |
| Normalized EBITDA | -1.7M | -2.0M | -3.2M | -3.1M | -4.1M | -- |
| Reconciled Depreciation | 287,000 | 287,000 | 325,000 | 392,000 | 479,000 | -- |
| Basic EPS | -0.57 | -0.85 | -1.16 | -- | -1.85 | -0.64 |
| Diluted EPS | -0.57 | -0.85 | -1.16 | -- | -1.85 | -0.64 |
| Basic Average Shares | 3.2M | 3.2M | 3.1M | -- | 3.1M | 2.2M |
| Diluted Average Shares | 3.2M | 3.2M | 3.1M | -- | 3.1M | 2.2M |
| Total Unusual Items | 170,000 | -415,000 | -82,000 | -2.2M | -1.2M | -- |
| Total Unusual Items Excluding Goodwill | 170,000 | -415,000 | -82,000 | -2.2M | -1.2M | -- |
| Tax Rate For Calcs | 0.00 | 0.15 | 0.00 | 0.15 | 0.02 | -- |
| Normalized Income | -2.0M | -2.3M | -3.6M | -4.9M | -4.5M | -- |
| Diluted NI Availto Com Stockholders | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| Impairment Of Capital Assets | 240,000 | -- | -- | 2.8M | 1.5M | -- |
| Net Income Continuous Operations | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| Net Non Operating Interest Income Expense | 14,000 | 60,000 | 36,000 | 418,000 | 188,000 | -- |
| Other Gand A | 2.1M | -- | -- | -1.1M | 3.0M | 3.0M |
| Reconciled Cost Of Revenue | 862,000 | 1.8M | 1.1M | 1.3M | 914,000 | -- |
| Total Expenses | 3.5M | 5.1M | 5.1M | 6.9M | 6.7M | -- |
| Total Operating Income As Reported | -2.3M | -2.4M | -3.6M | -6.4M | -6.3M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 8.5M | 9.3M | 13.8M | 16.4M | 20.0M | -- |
| Cash Cash Equivalents And Short Term Investments | 8.5M | 9.3M | 13.8M | 16.4M | 20.0M | -- |
| Cash Financial | -- | -- | -- | 16.4M | -- | -- |
| Accounts Receivable | 1.6M | 2.8M | 1.9M | 2.4M | 1.9M | -- |
| Receivables | 1.6M | 2.8M | 1.9M | 2.5M | 2.0M | -- |
| Inventory | 1.8M | 1.8M | 2.5M | 2.7M | 3.3M | -- |
| Prepaid Assets | 1.5M | 2.2M | 2.0M | 2.2M | 2.6M | -- |
| Other Current Assets | 156,000 | 319,000 | 325,000 | 210,000 | 312,000 | -- |
| Current Assets | 13.8M | 16.5M | 20.4M | 24.0M | 28.2M | -- |
| Gross PPE | 20.1M | 20.9M | 19.9M | 20.1M | 22.6M | -- |
| Accumulated Depreciation | -10.2M | -10.0M | -9.2M | -9.1M | -10.8M | -- |
| Net PPE | 9.9M | 10.9M | 10.7M | 11.0M | 11.8M | -- |
| Goodwill And Other Intangible Assets | -- | -- | -- | 0.00 | 1.8M | 3.3M |
| Other Intangible Assets | -- | -- | -- | -- | 1.8M | 3.3M |
| Other Non Current Assets | 132,000 | 132,000 | 128,000 | 123,000 | 126,000 | -- |
| Total Non Current Assets | 10.0M | 11.1M | 10.8M | 11.1M | 15.5M | -- |
| Total Assets | 23.9M | 27.6M | 31.1M | 35.1M | 43.8M | -- |
| Current Debt And Capital Lease Obligation | 212,000 | 209,000 | 253,000 | 271,000 | 405,000 | -- |
| Accounts Payable | 1.0M | 1.5M | 2.9M | 2.4M | 2.4M | -- |
| Payables | 1.1M | 1.6M | 3.0M | 2.5M | 2.6M | -- |
| Payables And Accrued Expenses | 1.8M | 2.6M | 4.1M | 4.2M | 4.5M | -- |
| Current Accrued Expenses | 650,000 | 967,000 | 1.0M | 1.7M | 1.9M | -- |
| Current Deferred Revenue | 19,000 | 19,000 | 122,000 | 120,000 | 46,000 | -- |
| Other Current Liabilities | 1.4M | 1.9M | 1.6M | 1.6M | 2.1M | -- |
| Current Liabilities | 4.0M | 5.5M | 7.1M | 7.2M | 8.2M | -- |
| Long Term Debt And Capital Lease Obligation | 2.0M | 2.0M | 2.0M | 2.0M | 1.2M | -- |
| Long Term Capital Lease Obligation | 2.0M | 2.0M | 2.0M | 2.0M | 1.2M | -- |
| Total Non Current Liabilities Net Minority Interest | 14.8M | 14.9M | 13.9M | 14.7M | 15.6M | -- |
| Total Liabilities Net Minority Interest | 18.8M | 20.5M | 21.0M | 21.9M | 23.8M | -- |
| Common Stock | 22.6M | 22.6M | 22.5M | 22.5M | 22.4M | -- |
| Capital Stock | 22.6M | 22.6M | 22.5M | 22.5M | 22.4M | -- |
| Additional Paid In Capital | 4.2M | 4.2M | 4.3M | 4.3M | 4.3M | -- |
| Retained Earnings | -19.0M | -17.2M | -14.7M | -12.1M | -5.2M | -- |
| Gains Losses Not Affecting Retained Earnings | -2.7M | -2.5M | -2.0M | -1.5M | -1.6M | -- |
| Other Equity Adjustments | -2.7M | -2.5M | -2.0M | -1.5M | -1.6M | -- |
| Common Stock Equity | 5.1M | 7.1M | 10.1M | 13.2M | 20.0M | -- |
| Stockholders Equity | 5.1M | 7.1M | 10.1M | 13.2M | 20.0M | -- |
| Total Equity Gross Minority Interest | 5.1M | 7.1M | 10.1M | 13.2M | 20.0M | -- |
| Total Capitalization | 5.1M | 7.1M | 10.1M | 13.2M | 20.0M | -- |
| Net Tangible Assets | 5.1M | 7.1M | 10.1M | 13.2M | 18.2M | -- |
| Tangible Book Value | 5.1M | 7.1M | 10.1M | 13.2M | 18.2M | -- |
| Working Capital | 9.9M | 11.0M | 13.3M | 16.8M | 20.1M | -- |
| Invested Capital | 5.1M | 7.1M | 10.1M | 13.2M | 20.0M | -- |
| Total Debt | 2.2M | 2.3M | 2.2M | 2.3M | 1.6M | -- |
| Share Issued | 3.2M | 3.2M | 3.1M | 3.1M | 3.1M | -- |
| Ordinary Shares Number | 3.2M | 3.2M | 3.1M | 3.1M | 3.1M | -- |
| Assets Held For Sale Current | 286,000 | -- | -- | -- | -- | -- |
| Buildings And Improvements | 3.7M | 3.7M | 3.6M | 3.6M | 2.9M | -- |
| Capital Lease Obligations | 2.2M | 2.3M | 2.2M | 2.3M | 1.6M | -- |
| Current Capital Lease Obligation | 212,000 | 209,000 | 253,000 | 271,000 | 405,000 | -- |
| Current Deferred Liabilities | 24,000 | 32,000 | 170,000 | 168,000 | 185,000 | -- |
| Current Provisions | 329,000 | 228,000 | 240,000 | 385,000 | 504,000 | -- |
| Employee Benefits | 11.8M | 11.8M | 11.0M | 11.7M | 12.5M | -- |
| Finished Goods | 361,000 | 658,000 | 197,000 | 299,000 | 312,000 | -- |
| Income Tax Payable | 118,000 | 118,000 | 109,000 | 105,000 | 113,000 | -- |
| Leases | 5.8M | 6.0M | 5.6M | 5.6M | 6.6M | -- |
| Long Term Provisions | -- | 46,000 | -- | -- | -- | -- |
| Machinery Furniture Equipment | 261,000 | 264,000 | 221,000 | 376,000 | 730,000 | -- |
| Non Current Accounts Receivable | -- | -- | -- | -- | 729,000 | 719,000 |
| Non Current Deferred Assets | -- | -- | -- | 0.00 | 1.1M | 952,000 |
| Non Current Deferred Liabilities | 1.0M | 1.0M | 930,000 | 914,000 | 1.9M | -- |
| Non Current Deferred Revenue | 1.0M | 1.0M | 930,000 | 914,000 | 1.9M | -- |
| Non Current Deferred Taxes Assets | -- | -- | -- | 0.00 | 1.1M | 952,000 |
| Other Inventories | -- | 1.0M | 1.8M | 2.0M | 2.4M | 2.3M |
| Other Properties | 10.3M | 11.0M | 10.5M | 10.5M | 12.4M | -- |
| Pensionand Other Post Retirement Benefit Plans Current | 288,000 | 574,000 | 758,000 | 607,000 | 432,000 | -- |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Raw Materials | 660,000 | 780,000 | 666,000 | 737,000 | 898,000 | -- |
| Taxes Receivable | 0.00 | 0.00 | 0.00 | 114,000 | 123,000 | -- |
| Total Tax Payable | 98,000 | 98,000 | 159,000 | 130,000 | 173,000 | -- |
| Work In Process | 738,000 | 383,000 | 1.6M | 1.7M | 2.1M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -676,000 | -4.4M | -1.9M | -3.0M | -7.8M | -- |
| Cash Flow From Continuing Operating Activities | -676,000 | -4.4M | -1.9M | -3.0M | -7.8M | -- |
| Depreciation And Amortization | 287,000 | 287,000 | 325,000 | 392,000 | 479,000 | -- |
| Depreciation Amortization Depletion | 287,000 | 287,000 | 325,000 | 392,000 | 479,000 | -- |
| Stock Based Compensation | -21,000 | -85,000 | 6,000 | 10,000 | 427,000 | -- |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 1.1M | -112,000 | -- |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 1.1M | -112,000 | -- |
| Change In Working Capital | 951,000 | -2.4M | 1.3M | 754,000 | -4.1M | -- |
| Changes In Account Receivables | 1.7M | -607,000 | 1.1M | -- | -978,000 | 427,000 |
| Change In Receivables | 1.7M | -607,000 | 1.3M | -- | -978,000 | 427,000 |
| Change In Inventory | -59,000 | 767,000 | -- | -- | -206,000 | 501,000 |
| Change In Payables And Accrued Expense | -927,000 | -2.2M | 238,000 | -- | -3.6M | 565,000 |
| Change In Other Working Capital | -355,000 | -172,000 | -413,000 | -- | 359,000 | -43,000 |
| Other Non Cash Items | 22,000 | 29,000 | 1,000 | -845,000 | -16,000 | -- |
| Capital Expenditure | -- | -49,000 | -615,000 | -309,000 | -131,000 | -157,000 |
| Purchase Of PPE | -- | -49,000 | -615,000 | -309,000 | -131,000 | -157,000 |
| Net PPE Purchase And Sale | 4,000 | -48,000 | -611,000 | -309,000 | -131,000 | -- |
| Sale Of Business | 0.00 | 0.00 | -- | 0.00 | 0.00 | 26.0M |
| Investing Cash Flow | 4,000 | -48,000 | -615,000 | -316,000 | 83,000 | -- |
| Cash Flow From Continuing Investing Activities | 4,000 | -48,000 | -615,000 | -316,000 | 83,000 | -- |
| Repayment Of Debt | -85,000 | -65,000 | -200,000 | -109,000 | -114,000 | -- |
| Net Issuance Payments Of Debt | -85,000 | -65,000 | -200,000 | -109,000 | -114,000 | -- |
| Financing Cash Flow | -85,000 | -107,000 | -200,000 | -202,000 | -188,000 | -- |
| Cash Flow From Continuing Financing Activities | -85,000 | -107,000 | -200,000 | -202,000 | -188,000 | -- |
| Effect Of Exchange Rate Changes | -52,000 | 177,000 | 60,000 | -88,000 | 78,000 | -- |
| Changes In Cash | -757,000 | -4.6M | -2.7M | -3.5M | -7.9M | -- |
| Beginning Cash Position | 9.3M | 13.8M | 16.4M | 20.0M | 27.8M | -- |
| End Cash Position | 8.5M | 9.3M | 13.8M | 16.4M | 20.0M | -- |
| Free Cash Flow | -676,000 | -4.5M | -2.5M | -3.3M | -7.9M | -- |
| Asset Impairment Charge | 316,000 | -- | -- | 2.8M | 1.5M | -- |
| Change In Prepaid Assets | 583,000 | -225,000 | 159,000 | -- | 266,000 | 368,000 |
| Depreciation | -- | -- | 325,000 | -- | -- | -- |
| Gain Loss On Investment Securities | -523,000 | 331,000 | 30,000 | -564,000 | -271,000 | -- |
| Long Term Debt Payments | -85,000 | -65,000 | -200,000 | -109,000 | -114,000 | -- |
| Net Business Purchase And Sale | 0.00 | 0.00 | -- | 0.00 | 0.00 | 26.0M |
| Net Income From Continuing Operations | -1.8M | -2.7M | -3.7M | -6.7M | -5.8M | -- |
| Net Long Term Debt Issuance | -85,000 | -65,000 | -200,000 | -109,000 | -114,000 | -- |
| Net Other Financing Charges | -- | -42,000 | -- | -- | -74,000 | -- |
| Net Other Investing Changes | -- | -- | -4,000 | -7,000 | 214,000 | -- |
| Operating Gains Losses | -412,000 | 448,000 | 116,000 | -454,000 | -136,000 | -- |
| Pension And Employee Benefit Expense | 111,000 | 117,000 | 86,000 | 110,000 | 135,000 | -- |
| Proceeds From Stock Option Exercised | -- | -- | -- | -93,000 | -74,000 | 0.00 |
| Sale Of PPE | 4,000 | 1,000 | 4,000 | -- | 0.00 | 0.00 |